A Pilot Trial of Suramin in Metastatic Breast Cancer to Assess Antiangiogenic Activity in Individual Patients

Publisher： Karger

E-ISSN： 1423-0232|58|4|324-333

ISSN： 0030-2414

Source： Oncology, Vol.58, Iss.4, 2000-05, pp. : 324-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 1, 2000-03 ,pp. : 60-62

Karger

Access to resources Recommend Favorite

Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 2-8

Karger

Access to resources Recommend Favorite

Final Safety and Efficacy Analysis of a Phase I/II Trial with Imatinib and Vinorelbine for Patients with Metastatic Breast Cancer

By  

Oncology, Vol. 87, Iss. 5, 2014-08 ,pp. : 300-310

Karger

Access to resources Recommend Favorite

Phase II Trial of Pegylated Liposomal Doxorubicin-Cyclophosphamide Combination as First-Line Chemotherapy in Older Metastatic Breast Cancer Patients

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 210-214

Karger

Access to resources Recommend Favorite

A Retrospective Analysis of the Activity and Safety of Oral Etoposide in Heavily Pretreated Metastatic Breast Cancer Patients

By  

THE BREAST JOURNAL, Vol. 21, Iss. 3, 2015-05 ,pp. : 241-245

John Wiley & Sons Inc

Access to resources Recommend Favorite